Interaction of vitamin K antagonists with heparin affect monitoring by activated clotting times

Background Unfractionated heparin is recommended during atrial fibrillation (AF) ablation to achieve activated clotting time (ACT) above 250–300 s to prevent clot. Many patients on therapeutic international normalised ratio (INR) undergo AF ablation procedures; however, it is unknown whether they re...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of interventional cardiac electrophysiology Vol. 27; no. 2; pp. 89 - 94
Main Authors:	Muntwyler, Jorg, Attenhofer Jost, Christine H., Diefenbacher, Werner, Beer, Jürg H., Nikolic, Rada, Amanpour, Feri, Faeh-Gunz, Anja, Naegeli, Barbara, Straumann, Edwin H., Maurer, Dominik, Candinas, Reto, Dang, Lam, Scharf, Christoph
Format:	Journal Article
Language:	English
Published:	Boston Springer US 01-03-2010 Springer Nature B.V
Subjects:	Anticoagulants Cardiology Drug Interactions Female Heparin - administration & dosage Humans International Normalized Ratio - methods Male Medicine Medicine & Public Health Middle Aged Reproducibility of Results Sensitivity and Specificity Vitamin K - antagonists & inhibitors Whole Blood Coagulation Time - methods Radiofrequency ablation INR Heparin
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Background Unfractionated heparin is recommended during atrial fibrillation (AF) ablation to achieve activated clotting time (ACT) above 250–300 s to prevent clot. Many patients on therapeutic international normalised ratio (INR) undergo AF ablation procedures; however, it is unknown whether they require less heparin to achieve similar ACT levels. Methods During AF ablation, the ACT was measured before and 10 min after administration of i.v. unfractionated heparin in patients with and without anticoagulation. The association of INR, heparin, pre-procedure ACT and body weight with ACT after heparin administration was tested using multivariable linear regression models. Results The subjects of this study were 149 patients undergoing AF ablation, among them 40 (27%) with subtherapeutic INR < 2, 79 (53%) with an INR between 2 and 3, and 30 (20%) patients with INR > 3. Baseline ACT was associated with INR ( r = 0.33, p < 0.001). After a mean of 8,685 ± 2,015 U (range, 5,000–15,000 IU) unfractionated heparin, univariate predictors of ACT were baseline INR ( p < 0.001), heparin dose ( p = 0.012) and baseline ACT ( p = 0.027). In the multivariable model, baseline INR (part r = 0.64, p < 0.001) and heparin dose (part r = 0.33, p < 0.001) strongly predicted post-heparin ACT. Estimated from the regression model, the heparin dose reductions by approximately one third in those with an INR of 2–3 and by at least two thirds in those with an INR above 3 may be favourable. Over the following 3 months, no thromboembolism and acute bleeding were observed. Conclusion The INR was the strongest predictor of post-heparin ACT, even more important than the heparin dose itself. The reduction of heparin dose by one third if INR is between 2–3 and by two thirds if INR is above 3 may be favourable.
ISSN:	1383-875X 1572-8595
DOI:	10.1007/s10840-009-9458-8